TJX vs VIR · P/E 32, rev $29.50B vs rev $238.9M
The TJX Companies Inc (TJX) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
TJX currently screens at market cap $181.32B and trailing P/E 31.9. VIR currently screens at market cap $1.45B.
Not investment advice. Open the TJX and VIR stock pages for the full models.
Not investment advice.